Discouraging inappropriate antibiotic use will require changing how patients and physicians are reimbursed for antibiotic prescriptions, and how physicians are paid for prescribing them.
Antibiotic resistance stems from insufficient incentives for patients, physicians, hospitals, and drug companies to do the right thing.
Dates of Project: May 2005 to December 2011
Field of Work: Antibiotic resistance
Problem Synopsis: Modern medicine depends on antibiotics to control bacterial infections, but pathogens resistant to antibiotics have emerged and spread rapidly. The Institute of Medicine and many others have sounded urgent calls to address this growing threat, yet policy-makers have done little to respond.
Synopsis of the Work: Extending the Cure researchers evaluated antibiotics and resistance of them, and proposed incentives to make the best use of existing antibiotics and encourage the discovery of new ones. The researchers framed the problem as one of “the commons”: antibiotics are a shared resource like clean air and safe drinking water, and any use of these drugs diminishes their overall effectiveness.
Key Results: Extending the Cure researchers:
- Published Extending the Cure: Policy Responses to the Growing Threat of Antibiotic Resistance, which concludes that patients, physicians, hospitals, and drug companies have insufficient incentives to conserve the effectiveness of existing antibiotics. What is good for each patient and entity conflicts with what is good for society.
- Published 23 journal articles, and 13 policy briefs on antibiotic resistance and potential responses.
- Launched the Drug Resistance Index, which tracks the resistance of microbes that cause common diseases, based on their resistance to individual drugs and the frequency with which clinicians prescribe them.
- Developed the ResistanceMap, which shows changes in antibiotic use and the resistance of microbes to individual drugs across North America and Europe.
Related antibiotics create cross-resistance, so each drug company has little incentive to consider resistance if other firms are selling similar drugs.
#Superbugs. Public stewardship of antibiotics essential to wise use by docs, drug cos., and patients.
The What's Next Health series features leading thinkers and visionaries. Stanford social scientist & innovator BJ Fogg discusses his model f...
We create new opportunities for better health by investing in health where it starts—in our homes, schools, and jobs.
As smartphone technology becomes ever more ubiquitous and the dangers of tobacco become ever more apparent, it’s not surprising that there a...
RWJF Nurse Faculty Scholar Jennifer Bellot writes about losing her grandmother to complications from a medical error.
Helping us understand what’s driving high health care costs is why we need more transparency in the prices, costs and quality of health care...
NewPublicHealth spoke with the Julio Frenk, MD, MPH, PHD, Dean of the Harvard School of Public Health, about how public health has changed o...
Executive Nurse Fellow Jerry Mansfield explains why the University Hospital and the Richard M. Ross Heart Hospital do not have a BSN-only hi...
Developing small community homes as alternatives to nursing homes, this radical, new national model for skilled nursing care returns control...
A new study finds healthier school meals standards could mean lower obesity rates among lower-income children. Read a Q&A with the author.
List of most current annual reports.
FDA: Certain HeartStart AEDs May Not Work During Cardiac Emergencies - NHTSA: Motorcoaches, Large Buses to Require Seatbelts for All Passeng...
Some individuals get to optimize their health while others are denied such opportunities; inefficiencies, inequities, and persistent dispari...